Eva Novotna
Charles University, Czech Republic
Biography
Eva Novotna has her expertise in the preparation and purification of recombinant enzymes. She studies interactions of potential inhibitors with carbonyl reducing enzymes using human recombinant enzymes and cancer cell lines. Her research interest include: carbonyl reducing enzymes, inhibitors and cancer drug resistance.
Abstract
Abstract : Dinaciclib effectively inhibits AKR1C3, a promising therapeutic target for cancer treatment